US EditionPublished • loading... • Updated
Johnson & Johnson Marks 10 Million Implants for Tecnis Eyhance IOL
Summary by Eyewire+
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Johnson & Johnson Marks 10 Million Implants for Tecnis Eyhance IOL
Johnson & Johnson announced that its Tecnis Eyhance IOL, which the company describes as the first enhanced monofocal IOL, has been implanted in more than 10 million eyes worldwide. “Reaching over 10 million implants is not just a volume milestone—it is validation that Tecnis Eyhance IOL delivers consistent, real-world outcomes at scale,” said Paul Lisenby, Global Head of R&D, Vision at Johnson & Johnson. “That level of adoption reflects years of…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
